Stay updated with breaking news from Tom Lemberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Checkable Medical, a startup that offers unique at-home tests...
/PRNewswire/ -- Amendola Communications, a nationally recognized, award-winning healthcare and technology public relations and marketing firm, announced today...
MedCity News Curebase raises $15M for decentralized clinical trials Curebase, a startup building software for decentralized clinical trials, raised $15 million in funding. The startup ran six trials related to Covid-19 in the last year. Shares0 After the Covid-19 pandemic put several clinical trials on hold, many companies were forced to shift to a virtual approach to resume their research. This presented an opportunity for startups providing decentralized clinical trials services, a once nascent but now booming business — even CVS Health recently launched its own decentralized clini...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Curebase Unlocks Drug Development With Remote Clinical Trials; Raises $15M Led By GGV Capital News provided by Share this article Share this article SAN FRANCISCO, May 25, 2021 /PRNewswire/ -- Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor. The financing was led by GGV Capital with participation from Xfund, Bold Capital, and several other institutional funds, and brin...